Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infections

Area of Science:

• Pulmonary Medicine
• Nanotechnology
• Infectious Diseases

Background:

• Chronic lung diseases, such as cystic fibrosis (CF), are complicated by recurrent pulmonary infections.
• CF airways present a unique environment with viscous mucus, promoting bacterial colonization and antibiotic resistance.
• Current treatment strategies face challenges due to pathogen complexity and patient tolerance to drug combinations.

Purpose of the Study:

• To explore a microparticle antibiotic delivery system for localized and sustained antibiotic dosing in pulmonary infections.
• To demonstrate the feasibility of managing CF-related lung infections using advanced drug delivery.

Main Methods:

• Development and testing of polymerized cyclodextrin microparticles for antibiotic delivery.
• Evaluation of the system's efficacy using preclinical in vitro and in vivo models of CF lung infections.

Main Results:

• The study demonstrated the feasibility of efficient, localized antibiotic delivery via microparticles.
• Polymerized cyclodextrin microparticles proved effective in preclinical CF infection models.
• Site-directed management of pulmonary infections was achieved.

Conclusions:

• Polymerized cyclodextrin microparticles represent a viable strategy for targeted antibiotic delivery in pulmonary infections.
• This approach offers a promising proof-of-concept for managing challenging lung infections in CF patients.
• The developed microparticle system shows potential for improving treatment outcomes in chronic lung diseases.